Julian Adams | CEO |
Ronit Simantov | Chief Medical Officer |
Shai Lankry | CFO |
Thomas Klima | Chief Commercial Officer |
Gregory Renza | RBC Capital Markets |
Chad Messer | Needham & Company |
Welcome to today's call during which we will provide an update on the company and review our financial results for the Second Quarter of 2019. With me here today are Julian Adams, Chief Executive Officer, Ronit Simantov, Chief Medical Officer, Shai Lankry, Chief Financial Officer and Tom Klima, Chief Commercial Officer and Tracey Lodie, Chief Scientific Officer.
Following our remarks we will open the call for Q&A.
We also issued a press release this morning summarizing our financial results and progress across the company, which is available on our website at www.gamida-cell.com.
During this call, we may make forward looking statements about our future expectations and plans, including clinical development objectives, the therapeutic potential of our product candidates, our operational plans and strategies and projected operating expenses and cash runway.